Functional pathology testing for neurotransmitters may offer some insights for practitioners who are treating depression, anxiety, insomnia and chronic pain. Beth Bundy talks testing benefits and pitfalls.
Improvements in brain white matter may be a good predictive measure of omega 3 benefit in depression.
Evidence shows that certain complementary medicines hold great value in the treatment of mood disorders. We take a look at some of the recent research.
Serum levels of vitamin B12 play an important role in cognitive and mental health. Observational studies have found as many as 30% of patients hospitalised for depression to be deficient in vitamin B12.
Dietician, and mother-of-two, Belinda Reynolds takes us through postpartum nourishment for a healthy mind, body and baby.
"The success of antidepressant drug therapy is not high, with studies suggesting 19-60% of patients are unresponsive to the treatment". Optimal methylation seems to be one very important piece of the mood puzzle.
Pyroluria is an emerging consideration in the treatment of mood disorders. In this podcast, Dr Mark Donohoe explores the integrative therapists approach.
Depression and anxiety disorders are exploding in prevalence. It is believed that at least 3 million Australians, at any given time, suffer from these conditions. And, while we do have standard medication for many psychiatric and psychological conditions, research shows that anywhere between 60-90% of people prescribed antidepressants fail to get a benefit that is superior to placebo. What these statistics suggest is that we are not addressing the underlying causes.